Clinical trial
Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant…
NCT00182455 · McMaster University, Other · Terminated
Key facts
| NCT number | NCT00182455 |
|---|---|
| Title | Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP) |
| Official title | Topiramate Augmentation to a Selective Serotonin Re-uptake Inhibitor (SSRI) in Treatment-Resistant Generalized Social Phobia: A Double-Blind Placebo -Controlled Trial. |
| Lead sponsor | McMaster University, Other |
| Collaborators | Janssen-Ortho Inc., Canada Industry Hamilton Health Sciences Corporation |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Social Phobia |
| Intervention type | Drug |
| Interventions | Topiramate, Placebo |
| Enrollment | 12 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2018 |
| Completion | Dec 1, 2018 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 2, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: